Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Strategy Officer, The Discovery Labs Christopher Murphy, Vice President and General Manager, Viral Vector Services, Thermo Fisher Scientific, Pharma Services Group Thomas VanCott, PhD, Global Head of Product Development, Cell & Gene Therapy, Catalent Cell & Gene Therapy Moderators: Rita Peters, Editorial Director, BioPharm International and Pharmaceutical Technology Feliza Mirasol, Science Editor, BioPharm International and Pharmaceutical Technology